Aspen Forecasts >2 Billion Rand Africa Mounjaro Sales Amid Expansion
Aspen Pharmacare expects Africa Mounjaro sales to surpass 2 billion rand in the current fiscal year, driven by strong South Africa demand and upcoming launches in Nigeria and Kenya. This could meaningfully boost Aspen's revenue mix and diversification, though upside depends on Lilly's supply, pricing, and regulatory approvals across Africa.
View signal analysis